Evaluation of TypeSeq a Novel High-Throughput Low-Cost Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes

摘要

BackgroundHuman papillomaviruses (HPV) cause over 500 000 cervical cancers each year, most of which occur in low-resource settings. Human papillomavirus genotyping is important to study natural history and vaccine efficacy. We evaluated TypeSeq, a novel, next-generation, sequencing-based assay that detects 51 HPV genotypes, in 2 large international epidemiologic studies.